Viewing Study NCT07214766


Ignite Creation Date: 2025-12-24 @ 4:34 PM
Ignite Modification Date: 2025-12-25 @ 2:26 PM
Study NCT ID: NCT07214766
Status: RECRUITING
Last Update Posted: 2025-12-04
First Post: 2025-10-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy Male Participants
Sponsor: Genentech, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module